福安藥業(集團)股份有限公司成立于2004年2月25日(ri),公司位于重(zhong)慶市長壽經濟(ji)技(ji)(ji)術開(kai)發區,占地面(mian)積約(yue)100畝,建筑(zhu)面(mian)積3萬余(yu)平方米,注冊資本(ben)11.89億元(yuan)。是長壽經濟(ji)技(ji)(ji)術開(kai)發區在深圳(zhen)創業板成功(gong)上市的企業(2011年3月22日(ri) 股票代碼:300194)。
公(gong)(gong)(gong)(gong)司(si)(si)(si)旗下(xia)擁有(you)(you)9家全資(zi)(zi)及(ji)控(kong)(kong)股(gu)子(zi)公(gong)(gong)(gong)(gong)司(si)(si)(si),分別為:2008年(nian)(nian)3月(yue)(yue)成立的(de)(de)從(cong)(cong)事(shi)(shi)藥(yao)(yao)品(pin)研(yan)發的(de)(de)全資(zi)(zi)子(zi)公(gong)(gong)(gong)(gong)司(si)(si)(si)福(fu)安(an)藥(yao)(yao)業(ye)(ye)(ye)集團(tuan)重慶(qing)禮(li)邦藥(yao)(yao)物(wu)開發有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、2009年(nian)(nian)7月(yue)(yue)全資(zi)(zi)收購的(de)(de)以制劑(ji)生產(chan)為主營業(ye)(ye)(ye)務的(de)(de)福(fu)安(an)藥(yao)(yao)業(ye)(ye)(ye)集團(tuan)慶(qing)余堂(tang)制藥(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)和主要(yao)從(cong)(cong)事(shi)(shi)藥(yao)(yao)品(pin)銷售業(ye)(ye)(ye)務的(de)(de)重慶(qing)生物(wu)制品(pin)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、2011年(nian)(nian)8月(yue)(yue)全資(zi)(zi)控(kong)(kong)股(gu)以制劑(ji)生產(chan)為主營業(ye)(ye)(ye)務的(de)(de)福(fu)安(an)藥(yao)(yao)業(ye)(ye)(ye)集團(tuan)湖北人民制藥(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、2013年(nian)(nian)8月(yue)(yue)20日控(kong)(kong)股(gu)子(zi)公(gong)(gong)(gong)(gong)司(si)(si)(si)福(fu)安(an)藥(yao)(yao)業(ye)(ye)(ye)集團(tuan)重慶(qing)凱斯特醫(yi)藥(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、2014年(nian)(nian)3月(yue)(yue)全資(zi)(zi)控(kong)(kong)股(gu)的(de)(de)從(cong)(cong)事(shi)(shi)醫(yi)藥(yao)(yao)中間體生產(chan)的(de)(de)廣安(an)凱特制藥(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、2015年(nian)(nian)5月(yue)(yue)全資(zi)(zi)控(kong)(kong)股(gu)的(de)(de)福(fu)安(an)藥(yao)(yao)業(ye)(ye)(ye)集團(tuan)寧波天衡(heng)制藥(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、2016年(nian)(nian)6月(yue)(yue)全資(zi)(zi)控(kong)(kong)股(gu)的(de)(de)煙臺只(zhi)楚(chu)藥(yao)(yao)業(ye)(ye)(ye)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、2016年(nian)(nian)9月(yue)(yue)從(cong)(cong)集團(tuan)公(gong)(gong)(gong)(gong)司(si)(si)(si)剝離成立的(de)(de)福(fu)安(an)藥(yao)(yao)業(ye)(ye)(ye)集團(tuan)重慶(qing)博圣制藥(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)。
公(gong)司(si)主要從事原料藥及制劑的(de)生產、銷售。目前公(gong)司(si)主要涉及的(de)領域有抗感染、抗腫瘤、精神神經系統、心腦血管(guan)、消化系統、內分泌(mi)及代謝、骨骼與(yu)肌(ji)肉系統等(deng)。
集團公司(si)現有職工(gong)1900余人,其(qi)中博士5名,碩士48名,本科學歷404人,人才(cai)梯(ti)次和結構合理。公司(si)將積極推進產(chan)(chan)品(pin)結構的(de)(de)優化、加快(kuai)產(chan)(chan)品(pin)研發(fa)和科研成果的(de)(de)產(chan)(chan)業化,努力完成由抗(kang)生素(su)產(chan)(chan)品(pin)占(zhan)據(ju)主導地位向(xiang)抗(kang)生素(su)與專(zhuan)科用藥協(xie)同發(fa)展的(de)(de)戰略調(diao)整,為(wei)公司(si)的(de)(de)未(wei)來發(fa)展奠定堅實基礎。